Abbott Laboratories is showing strong growth potential with rising sales and EPS, though slightly overvalued. See why we are neutral on ABT stock.

If a company's history and track record were good enough reasons to buy its shares, it'd be easy to make a case for investing in Abbott Laboratories ( ABT 1.52%). Abbott is a longtime leader in the healthcare sector, and has generally delivered excellent returns to long-term shareholders.

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*.